Current trends in treatment and management of Neuropathic pain: Use of carrier approaches
Neuropathic pain arises from a lesion or disease of the somatosensory nervous system and can substantially impair quality of life. Incomplete pain relief and adverse effects associated with conventional pharmacotherapy have prompted research into carrier-based strategies designed to improve drug delivery. This narrative review summarizes the pathophysiology of neuropathic pain and examines lipid-based, polymeric, and biomimetic carriers, with particular emphasis on intranasal nose-to-brain delivery. The platforms reviewed include liposomes, solid lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, polymeric nanoparticles, hydrogels, extracellular vesicles, and cell membrane-coated nanoparticles. Depending on their composition and route of administration, these systems can improve drug solubility and stability, sustain release, and increase exposure at target sites. Intranasal formulations may improve nasal residence and mucosal permeation, while transport along olfactory and trigeminal pathways offers a potential route to the central nervous system that can bypass the blood–brain barrier. Preclinical studies suggest that selected formulations can increase brain drug exposure or prolong analgesic effects. Clinical translation requires confirmation of efficacy and long-term safety in humans, alongside reproducible manufacturing and consistent nasal dosing. Carrier-based delivery offers a promising approach to neuropathic pain management, with clinical studies needed to determine which formulations and patient populations are most likely to benefit.
